MF
TXG icon

Magnetar Financial’s 10x Genomics TXG Stock Holding History

Magnetar Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,706
Closed -$289K – 1216
2025
Q3 		$289K Buy
+24,706
New +$322K ﹤0.01% 710
2024
Q3 		– Sell
-195,762
Closed -$3.81M – 698
2024
Q2 		$3.81M Buy
195,762
+105,500
+117% +$2.76M 0.08% 139
2024
Q1 		$3.39M Buy
+90,262
New +$3.97M 0.08% 153
2023
Q4 		– Sell
-12,616
Closed -$520K – 551
2023
Q3 		$520K Buy
12,616
+6,863
+119% +$357K 0.01% 322
2023
Q2 		$321K Buy
+5,753
New +$311K 0.01% 390
2022
Q2 		– Sell
-10,099
Closed -$768K – 1826
2022
Q1 		$768K Buy
+10,099
New +$883K 0.01% 850

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Magnetar Financial's TXG Position: Q4 2025 in Review

Magnetar Financial sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 24,706 shares — an estimated $289K sold.

Magnetar Financial first reported a position in TXG in Q1 2022 and held it in 6 quarters. The position peaked at $3.81M in Q2 2024. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Magnetar Financial reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Magnetar Financial sold 24,706 10x Genomics shares in Q4 2025, an estimated $289K.
  • Magnetar Financial first reported a position in 10x Genomics in Q1 2022 and held it in 6 quarters.
  • Magnetar Financial's 10x Genomics position peaked at $3.81M in Q2 2024.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Magnetar Financial's 13F filing for Q4 2025, filed 17 Feb 2026.